Related Experiment Videos
Flecainide: evidence of non-linear kinetics
G Boriani1, E Strocchi, A Capucci
1Institute of Cardiovascular Diseases, University of Bologna, Italy.
European Journal of Clinical Pharmacology
|January 1, 1991
Summary
Flecainide
Area of Science:
- Clinical Pharmacology
- Cardiac Electrophysiology
Background:
- Flecainide is an antiarrhythmic drug used for ventricular arrhythmias.
- Understanding flecainide pharmacokinetics is crucial for safe and effective treatment.
Purpose of the Study:
- To investigate the pharmacokinetics of flecainide in patients with ventricular arrhythmias.
- To compare flecainide kinetics after single versus chronic administration.
Main Methods:
- Pharmacokinetic analysis in 12 patients with ventricular arrhythmias.
- Single and chronic dose administration of flecainide.
- Measurement of plasma flecainide levels, half-life, and AUC.
Main Results:
- Flecainide half-life and AUC significantly increased during chronic treatment.
- Observed non-linear kinetics, even in patients with normal organ function.
- Increases in plasma flecainide levels were unpredictable.
Conclusions:
- Flecainide exhibits non-linear pharmacokinetics during chronic treatment.
- Plasma flecainide levels can increase unpredictably, necessitating close monitoring.
- Therapeutic drug monitoring is recommended for flecainide therapy.